SARS-CoV-2 M(pro) inhibitors: identification of anti-SARS-CoV-2 M(pro) compounds from FDA approved drugs

Recent outbreak of COVID-19 pandemic caused by severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2) has raised serious global concern for public health. The viral main 3-chymotrypsin-like cysteine protease (M(pro)), known to control coronavirus replication and essential for viral life cycle,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Biomol Struct Dyn
Main Authors: Bharadwaj, Shiv, Azhar, Esam Ibraheem, Kamal, Mohammad Amjad, Bajrai, Leena Hussein, Dubey, Amit, Jha, Kanupriya, Yadava, Umesh, Kang, Sang Gu, Dwivedi, Vivek Dhar
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651494/
https://ncbi.nlm.nih.gov/pubmed/33150855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1842807
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados